ESTA
Establishment Labs Holdings Inc

452
Mkt Cap
$1.44B
Volume
447,168.00
52W High
$51.34
52W Low
$26.56
PE Ratio
-16.21
ESTA Fundamentals
Price
$49.59
Prev Close
$49.85
Open
$50.00
50D MA
$41.13
Beta
1.79
Avg. Volume
263,778.57
EPS (Annual)
-$3.00
P/B
63.11
Rev/Employee
$163,089.39
Loading...
Loading...
News
all
press releases
Medpace (MEDP) Beats Q3 Earnings and Revenue Estimates
Medpace (MEDP) delivered earnings and revenue surprises of +10.29% and +3.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2d ago
News Placeholder
More News
News Placeholder
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, plans to...
Business Wire·2d ago
News Placeholder
Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, noted the...
Business Wire·10d ago
News Placeholder
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, announced...
Business Wire·15d ago
News Placeholder
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Misses Revenue Estimates
Establishment Labs (ESTA) delivered earnings and revenue surprises of -5.56% and -0.59%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates
CareDx (CDNA) delivered earnings and revenue surprises of -16.67% and -4.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
CVS Health (CVS) Beats Q2 Earnings and Revenue Estimates
CVS Health (CVS) delivered earnings and revenue surprises of +23.13% and +5.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick
Investing.com -- Citi analysts revised their MedTech coverage following a volatile first quarter, with several rating changes and adjustments to target prices.
investing.com·5mo ago
News Placeholder
Establishment Labs to Present at TD Cowen's 45th Annual Health Care Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today...
Business Wire·8mo ago
News Placeholder
Establishment Labs to Present at Citis 2025 Unplugged Medtech and Life Sciences Access Day
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today...
Business Wire·8mo ago

Latest ESTA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.